Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti‐tumor necrosis factor drug responses and skin‐blood DNA methylation age: Relationships in moderate‐to‐severe psoriasis

Experimental Dermatology(2020)10.1111/exd.14207Source: DataRank Database

Anti‐tumor necrosis factor drug responses and skin‐blood DNA methylation age: Relationships in moderate‐to‐severe psoriasis is a research paper published in Experimental Dermatology (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.33)OA: greenTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ugoji Nwanaji‐Enwerem,Andrea Baccarelli ORCID,Ramone F. Williams ORCID,Elena Colicino ORCID,Jamaji C. Nwanaji‐Enwerem ORCID

Live enrichment

PubMed:33015854 PMC:PMC8058824 OpenAlex:https://openalex.org/W3091277629

National Institutes of Health

Grant: P30ES023515

National Institutes of Health

Grant: 2P30ES023515-05

The Mount Sinai Transdisciplinary Center on Early Environmental Exposures

FWCI

0.33

Citation Percentile

0.6%

Citation Trend

2021

2023

2024

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8058824

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14207

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/exd.14207

journalhttps://doi.org/10.1111/exd.14207

Fields of Study

Epigenetics and DNA MethylationImmune responses and vaccinationsAdolescent and Pediatric Healthcare0301 basic medicine03 medical and health sciencesAdultBiomarkersCross-Sectional StudiesDNA MethylationEpigenesis, GeneticFemaleHumansMaleMiddle AgedPsoriasisTumor Necrosis Factor Inhibitors

MeSH Terms

Tumor Necrosis Factor InhibitorsAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPsoriasisBiomarkersDNA MethylationEpigenesis, Genetic

Keywords

PsoriasisMedicineTumor necrosis factor alphaBiomarkerDNA methylationWhite blood cellMethylationImmunologyInternal medicineOncologyGastroenterologyDNABiologyGene expressionGeneticsAgeingBiomarkersAnti-tnfEpigenetic ClockEpigenetic AgeDna Methylation AgeSkinblood ClockAdultMaleMiddle AgedEpigenesis, GeneticCross-Sectional StudiesHumansFemaleTumor Necrosis Factor Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being